"Mucormycosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infection in humans and animals caused by any fungus in the order Mucorales (e.g., Absidia, Mucor, Rhizopus etc.) There are many clinical types associated with infection of the central nervous system, lung, gastrointestinal tract, skin, orbit and paranasal sinuses. In humans, it usually occurs as an opportunistic infection in patients with a chronic debilitating disease, particularly uncontrolled diabetes, or who are receiving immunosuppressive agents. (From Dorland, 28th ed)
| Descriptor ID |
D009091
|
| MeSH Number(s) |
C01.703.980.600
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mucormycosis".
Below are MeSH descriptors whose meaning is more specific than "Mucormycosis".
This graph shows the total number of publications written about "Mucormycosis" by people in this website by year, and whether "Mucormycosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 3 | 0 | 3 |
| 2014 | 4 | 1 | 5 |
| 2016 | 2 | 0 | 2 |
| 2017 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mucormycosis" by people in Profiles.
-
Prabha N, Arora RD, George C A, Wankhade AB, Gupta AK, Gupta RK, Nagarkar NM. The COVID-19-Associated Mucormycosis with Cutaneous Involvement. Skinmed. 2024; 22(5):346-350.
-
Sun G, Weiss A, Zhao J, Silver M, DeMaio M, Dehbashi S. Isolated cerebral Mucormycosis and Aspergillosis coinfection in an immunocompromised adult. BMJ Case Rep. 2023 Aug 27; 16(8).
-
Nasir N, Farooqi J, Mahmood SF, Jabeen K. COVID-19 associated mucormycosis: a life-threatening complication in patients admitted with severe to critical COVID-19 from Pakistan. Clin Microbiol Infect. 2021 Nov; 27(11):1704-1707.
-
Allam SR, Madhrira MM, Memon IA, Tessier J, Johnson JA, Dao A, Rofaiel G. Invasive mucormycosis in a renal transplant recipient. Kidney Int. 2020 01; 97(1):216.
-
Fadhel M, Patel SV, Liu E, Fune L, Wasserman EJ, Asif A. Disseminated Pulmonary with Isolated Muscular Mucormycosis in an Acute Myeloid Leukemia Patient: A Case Report and Literature Review. Am J Case Rep. 2019 Aug 16; 20:1210-1215.
-
Katragkou A, Fisher BT, Groll AH, Roilides E, Walsh TJ. Diagnostic Imaging and Invasive Fungal Diseases in Children. J Pediatric Infect Dis Soc. 2017 Sep 01; 6(suppl_1):S22-S31.
-
Mulki R, Masab M, Eiger G, Perloff S. Lethargy and vision loss: successful management of rhinocerebral mucormycosis. BMJ Case Rep. 2016 Jun 02; 2016.
-
Mattioni J, Portnoy JE, Moore JE, Carlson D, Sataloff RT. Laryngotracheal mucormycosis: Report of a case. Ear Nose Throat J. 2016 Jan; 95(1):29-39.
-
Di Pentima MC, Chan S, Powell J, Napoli JA, Walter AW, Walsh TJ. Topical amphotericin B in combination with standard therapy for severe necrotizing skin and soft-tissue mucormycosis in an infant with bilineal leukemia: case report and review. J Pediatr Hematol Oncol. 2014 Oct; 36(7):e468-70.
-
Katragkou A, McCarthy M, Meletiadis J, Petraitis V, Moradi PW, Strauss GE, Fouant MM, Kovanda LL, Petraitiene R, Roilides E, Walsh TJ. In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds. Antimicrob Agents Chemother. 2014 Nov; 58(11):6934-7.